1. Home
  2. CRSP vs MAT Comparison

CRSP vs MAT Comparison

Compare CRSP & MAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$54.47

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Logo Mattel Inc.

MAT

Mattel Inc.

HOLD

Current Price

$13.93

Market Cap

4.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSP
MAT
Founded
2013
1945
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.5B
IPO Year
2016
1994

Fundamental Metrics

Financial Performance
Metric
CRSP
MAT
Price
$54.47
$13.93
Analyst Decision
Buy
Buy
Analyst Count
17
11
Target Price
$70.29
$20.90
AVG Volume (30 Days)
1.7M
4.0M
Earning Date
05-11-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
$289,590,000.00
$5,347,623,000.00
Revenue This Year
$807.72
$5.92
Revenue Next Year
$172.52
$5.08
P/E Ratio
N/A
$70.20
Revenue Growth
9169.85
N/A
52 Week Low
$44.12
$13.62
52 Week High
$78.48
$22.48

Technical Indicators

Market Signals
Indicator
CRSP
MAT
Relative Strength Index (RSI) 55.94 38.52
Support Level $47.48 N/A
Resistance Level $59.61 $15.38
Average True Range (ATR) 2.84 0.46
MACD 0.25 -0.05
Stochastic Oscillator 54.76 24.90

Price Performance

Historical Comparison
CRSP
MAT

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About MAT Mattel Inc.

Mattel manufactures and markets toy products that are sold to its wholesale partners and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2025, with the remainder stemming from international markets.

Share on Social Networks: